SE0300213D0 - Use of avian antibodies - Google Patents
Use of avian antibodiesInfo
- Publication number
- SE0300213D0 SE0300213D0 SE0300213A SE0300213A SE0300213D0 SE 0300213 D0 SE0300213 D0 SE 0300213D0 SE 0300213 A SE0300213 A SE 0300213A SE 0300213 A SE0300213 A SE 0300213A SE 0300213 D0 SE0300213 D0 SE 0300213D0
- Authority
- SE
- Sweden
- Prior art keywords
- infections
- microbe
- prophylaxis
- igy
- birds
- Prior art date
Links
- 241000271566 Aves Species 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 241000588697 Enterobacter cloacae Species 0.000 abstract 1
- 206010017964 Gastrointestinal infection Diseases 0.000 abstract 1
- 206010022678 Intestinal infections Diseases 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 235000013601 eggs Nutrition 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0300213A SE0300213D0 (sv) | 2003-01-30 | 2003-01-30 | Use of avian antibodies |
| ES04706915T ES2285419T3 (es) | 2003-01-30 | 2004-01-30 | Uso de anticuerpos aviares. |
| PCT/SE2004/000133 WO2004067035A1 (en) | 2003-01-30 | 2004-01-30 | Use of avian antibodies |
| DE602004005963T DE602004005963T2 (de) | 2003-01-30 | 2004-01-30 | Verwendung von vogelantikörpern |
| AT04706915T ATE359820T1 (de) | 2003-01-30 | 2004-01-30 | Verwendung von vogelantikörpern |
| EP04706915A EP1589995B1 (en) | 2003-01-30 | 2004-01-30 | Use of avian antibodies |
| US10/542,784 US20060134101A1 (en) | 2003-01-30 | 2004-01-30 | Use of avian antibodies |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0300213A SE0300213D0 (sv) | 2003-01-30 | 2003-01-30 | Use of avian antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE0300213D0 true SE0300213D0 (sv) | 2003-01-30 |
Family
ID=20290238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0300213A SE0300213D0 (sv) | 2003-01-30 | 2003-01-30 | Use of avian antibodies |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20060134101A1 (sv) |
| EP (1) | EP1589995B1 (sv) |
| AT (1) | ATE359820T1 (sv) |
| DE (1) | DE602004005963T2 (sv) |
| ES (1) | ES2285419T3 (sv) |
| SE (1) | SE0300213D0 (sv) |
| WO (1) | WO2004067035A1 (sv) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2614936A1 (en) * | 2005-07-10 | 2007-01-18 | Adaptive Spectrum And Signal Alignment, Inc. | Dsl system estimation |
| WO2007027321A2 (en) * | 2005-07-25 | 2007-03-08 | Avianax, Inc. | Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases |
| US8877187B2 (en) | 2005-07-25 | 2014-11-04 | Avianax, Llc | Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases |
| GB2482536B (en) | 2010-08-05 | 2013-07-24 | Hera Pharmaceuticals Inc | Expression of antibody or a fragment thereof in lactobacillus |
| GB2482535A (en) * | 2010-08-05 | 2012-02-08 | Hera Pharmaceuticals Inc | Expression of antibody or a fragment thereof in lactobacillus |
| MX340019B (es) | 2010-11-23 | 2016-06-22 | Pantheryx Inc | Composiciones y metodos para el tratamiento en aplicaciones clinicas de amplio espectro, no diferenciadas o combinadas. |
| CA2905375A1 (en) * | 2013-03-15 | 2014-09-18 | Camas Incorporated | Methods and compositions for reducing microorganisms in the oropharynx, nasopharynx and oral cavities |
| WO2020176637A1 (en) | 2019-02-26 | 2020-09-03 | Pantheryx, Inc. | Compositions for management of disorders of the gastrointestinal tract |
| JP7673968B2 (ja) * | 2019-12-03 | 2025-05-09 | 国立大学法人東海国立大学機構 | 光抗菌療法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5599539A (en) * | 1989-10-31 | 1997-02-04 | Ophidian Pharmaceuticals, Inc. | Therapy for clostridial botulinum toxin |
| ZA929143B (en) * | 1992-11-25 | 1993-08-16 | Michael Anthony Folan | Agents for use in the prophylaxis and therapy of fungal infections. |
| SE9701026D0 (sv) * | 1997-03-20 | 1997-03-20 | Immun System Ims Ab | use of avian antibodies |
-
2003
- 2003-01-30 SE SE0300213A patent/SE0300213D0/sv unknown
-
2004
- 2004-01-30 AT AT04706915T patent/ATE359820T1/de active
- 2004-01-30 EP EP04706915A patent/EP1589995B1/en not_active Expired - Lifetime
- 2004-01-30 WO PCT/SE2004/000133 patent/WO2004067035A1/en not_active Ceased
- 2004-01-30 ES ES04706915T patent/ES2285419T3/es not_active Expired - Lifetime
- 2004-01-30 US US10/542,784 patent/US20060134101A1/en not_active Abandoned
- 2004-01-30 DE DE602004005963T patent/DE602004005963T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1589995B1 (en) | 2007-04-18 |
| DE602004005963T2 (de) | 2008-01-17 |
| ES2285419T3 (es) | 2007-11-16 |
| US20060134101A1 (en) | 2006-06-22 |
| WO2004067035A1 (en) | 2004-08-12 |
| EP1589995A1 (en) | 2005-11-02 |
| ATE359820T1 (de) | 2007-05-15 |
| DE602004005963D1 (de) | 2007-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Abbas et al. | IgY antibodies for the immunoprophylaxis and therapy of respiratory infections | |
| CY1119445T1 (el) | Αντισωματα εναντι του ανθρωπινου gdf8 | |
| Linderman et al. | Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013–2014 influenza season | |
| Friesen et al. | A common solution to group 2 influenza virus neutralization | |
| PH12021550793A1 (en) | Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding Fragments | |
| ZA202308021B (en) | Anti-ctla4 antibodies and methods of making and using the same | |
| AR103868A1 (es) | Anticuerpos anti-cd47 como agentes terapéuticos | |
| BR112019008010A2 (pt) | anticorpo monoclonal isolado ou fragmento imunologicamente ativo do mesmo, anticorpo monoclonal biespecífico isolado, composição farmacêutica, método para tratamento de uma doença em um sujeito humano em necessidade do mesmo, proteína de fusão, epítopo imunodominante codificado pelo gene cd47, e, molécula biológica | |
| EA201891435A1 (ru) | Гуманизированные моноклональные антитела, моноклональные антитела мыши или химерные моноклональные антитела против cd47 | |
| Nagarajan et al. | Monoclonal antibodies for the prevention of rabies: theory and clinical practice | |
| Polanowski et al. | Immunomodulatory activity accompanying chicken egg yolk immunoglobulin Y | |
| MX2009006066A (es) | Tratamiento de cerdos con el antigeno pcv. | |
| NO20084539L (no) | Humaniserte monoklonale antistoffer til hepatocyttvekstfaktor | |
| BR112023016574A2 (pt) | Composições de anticorpo anti-tl1a e métodos de tratamento no pulmão | |
| Sudjarwo et al. | The potency of chicken egg yolk immunoglobulin (IgY) specific as immunotherapy to Mycobacterium tuberculosis infection | |
| UA113623C2 (uk) | Моноклональне антитіло проти інгібітору шляху тканинного фактора (tfpi) | |
| SE0300213D0 (sv) | Use of avian antibodies | |
| Lachmann | The use of antibodies in the prophylaxis and treatment of infections | |
| El-Kafrawy et al. | Immunotherapeutic efficacy of IgY antibodies targeting the full-length spike protein in an animal model of middle east respiratory syndrome coronavirus infection | |
| da Rocha et al. | Development of IgY antibodies against anti-snake toxins endowed with highly lethal neutralizing activity | |
| Redwan et al. | Ovine anti-rabies antibody production and evaluation | |
| BRPI0516677A (pt) | nonadepsipeptìdeos acilados como derivados de lysobactin | |
| EP4375295A4 (en) | Antibody drug for prevention or treatment of autoimmune diseases | |
| EA201390735A1 (ru) | Композиции вакцин с фрагментами расщепленных иммуноглобулинов | |
| Ibrahim et al. | Post-pandemic seroprevalence of human influenza viruses in domestic cats |